The law firm said it is reviewing whether certain Arcus Biosciences insiders breached fiduciary duties to shareholders and whether investors could seek damages or corporate governance reforms.
Kuehn Law, PLLC said it is investigating whether certain officers and directors of Arcus Biosciences, Inc. breached their fiduciary duties to shareholders in a matter centered on potential self-dealing. The firm said shareholders may be entitled to damages and corporate governance reforms if misconduct is established. The announcement was framed as an invitation for long-term RCUS stockholders to contact the firm. It said consultations are free, the case would carry no obligation, and Kuehn Law would pay all case costs without charging its investor clients. The firm also urged shareholders to act quickly, saying there may be limited time to enforce their rights.